Works matching DE "PLASMA cell leukemia"
Results: 229
PLASMA CELL LEUKAEMIA: A RARE CONDITION.
- Published in:
- Malaysian Journal of Medical Sciences, 2007, v. 14, p. 280
- By:
- Publication type:
- Article
Peripheral Blood Dendritic Cell Subsets from Patients with Monoclonal Gammopathies Show an Abnormal Distribution and Are Functionally Impaired.
- Published in:
- Oncologist, 2008, v. 13, n. 1, p. 1, doi. 10.1634/theoncologist.2007-0127
- By:
- Publication type:
- Article
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01159-8
- By:
- Publication type:
- Article
Extended DaraKRd: Are we enhancing outcomes by prolonging treatment?
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01070-2
- By:
- Publication type:
- Article
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00998-9
- By:
- Publication type:
- Article
Utility of flow cytometry screening before MRD testing in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00832-8
- By:
- Publication type:
- Article
Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00755-w
- By:
- Publication type:
- Article
I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00733-2
- By:
- Publication type:
- Article
Nutrition perceptions, needs and practices among patients with plasma cell disorders.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00587-0
- By:
- Publication type:
- Article
Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0336-z
- By:
- Publication type:
- Article
Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0253-1
- By:
- Publication type:
- Article
Circumferential gastric wall thickening as initial presentation of relapsed plasma cell leukemia.
- Published in:
- Clinical Endoscopy, 2024, v. 57, n. 1, p. 131, doi. 10.5946/ce.2022.291
- By:
- Publication type:
- Article
Targeting Oxidative Stress With Auranofin or Prima-1<sup>Met</sup> to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00128
- By:
- Publication type:
- Article
Acute Renal failure caused by plasma cell infiltration in primary plasma cell leukemia.
- Published in:
- Nephrology, 2017, v. 22, n. 9, p. 729, doi. 10.1111/nep.12928
- By:
- Publication type:
- Article
Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma.
- Published in:
- Acta Haematologica, 2016, v. 135, n. 2, p. 113, doi. 10.1159/000439424
- By:
- Publication type:
- Article
Significantly Better Prognosis for Patients with Primary Plasma Cell Leukemia than for Patients with Secondary Plasma Cell Leukemia.
- Published in:
- Acta Haematologica, 2007, v. 118, n. 3, p. 178, doi. 10.1159/000109470
- By:
- Publication type:
- Article
Two Cases of Plasma Cell Leukemia with Atypical Immunophenotype.
- Published in:
- Acta Haematologica, 2007, v. 118, n. 1, p. 27, doi. 10.1159/000101557
- By:
- Publication type:
- Article
Thalidomide Administration for the Treatment of Resistant Plasma Cell Leukemia.
- Published in:
- 2003
- By:
- Publication type:
- Case Study
Systemic Capillary Leak Syndrome Preceding Plasma Cell Leukaemia.
- Published in:
- Acta Haematologica, 2001, v. 106, n. 3, p. 118, doi. 10.1159/000046600
- By:
- Publication type:
- Article
Long-Term Survival in Primary Plasma Cell Leukemia after Therapy with VAD, Autologous Blood Stem Cell Transplantation and Interferon-Alpha.
- Published in:
- Acta Haematologica, 1999, v. 101, n. 4, p. 193, doi. 10.1159/000040952
- By:
- Publication type:
- Article
A Plasma Cell Leukemia Patient Showing Bialleic 14q Translocations: t(2;14) and t(11;14).
- Published in:
- Acta Haematologica, 1999, v. 101, n. 4, p. 197, doi. 10.1159/000040953
- By:
- Publication type:
- Article
Relapsed plasma cell leukaemia manifesting as a protein-losing enteropathy.
- Published in:
- 2006
- By:
- Publication type:
- Other
research paper CD27-triggering on primary plasma cell leukaemia cells has anti-apoptotic effects involving mitogen activated protein kinases.
- Published in:
- British Journal of Haematology, 2004, v. 124, n. 3, p. 299, doi. 10.1046/j.1365-2141.2003.04783.x
- By:
- Publication type:
- Article
Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma.
- Published in:
- British Journal of Haematology, 2003, v. 122, n. 5, p. 728, doi. 10.1046/j.1365-2141.2003.04481.x
- By:
- Publication type:
- Article
Efficacy of thalidomide in the treatment of vad-refractory plasma cell leukaemia appearing after autologous stem cell transplantation for multiple myeloma.
- Published in:
- British Journal of Haematology, 2002, v. 117, n. 4, p. 996, doi. 10.1046/j.1365-2141.2002.03537_4.x
- By:
- Publication type:
- Article
Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy
- Published in:
- 2024
- By:
- Publication type:
- Letter
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3691, doi. 10.1007/s00277-024-05862-1
- By:
- Publication type:
- Article
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2943, doi. 10.1007/s00277-023-05362-8
- By:
- Publication type:
- Article
Successful eradication of central nervous system infiltration of primary plasma cell leukemia by temozolomide.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Sequential development of monoclonal B cell lymphocytosis-derived small lymphocytic lymphoma and plasma cell leukemia.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 2, p. 257, doi. 10.1007/s00277-014-2211-0
- By:
- Publication type:
- Article
Clinical features and treatment outcomes of lymphoplasmacytic lymphoma: a single center experience in Korea.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 10, p. 1011, doi. 10.1007/s00277-010-0978-1
- By:
- Publication type:
- Article
Plasma cell leukemia: a rare condition.
- Published in:
- Annals of Hematology, 2006, v. 85, n. 4, p. 263, doi. 10.1007/s00277-005-0054-4
- By:
- Publication type:
- Article
Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 209, doi. 10.3390/biomedicines10020209
- By:
- Publication type:
- Article
LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients.
- Published in:
- Biomedicines, 2021, v. 9, n. 11, p. 1637, doi. 10.3390/biomedicines9111637
- By:
- Publication type:
- Article
Plasma Cell Leukemia of the Breast.
- Published in:
- Breast Journal, 2008, v. 14, n. 2, p. 204, doi. 10.1111/j.1524-4741.2008.00559.x
- By:
- Publication type:
- Article
Successful intrathecal chemotherapy combined with radiotherapy followed by pomalidomide and low-dose dexamethasone maintenance therapy for a primary plasma cell leukemia patient.
- Published in:
- Hematology Reports, 2017, v. 9, n. 1, p. 28, doi. 10.4081/hr.2017.6986
- By:
- Publication type:
- Article
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
- Published in:
- Oncogene, 2005, v. 24, n. 15, p. 2461, doi. 10.1038/sj.onc.1208447
- By:
- Publication type:
- Article
Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature.
- Published in:
- Clinical & Experimental Dermatology, 2005, v. 30, n. 4, p. 391, doi. 10.1111/j.1365-2230.2005.01788.x
- By:
- Publication type:
- Article
Atypical Morphological Presentation of Neoplastic Plasma Cells: A Series of Five Cases.
- Published in:
- Journal of Clinical & Diagnostic Research, 2024, v. 18, n. 1, p. 1, doi. 10.7860/JCDR/2024/67679.18959
- By:
- Publication type:
- Article
Aberrant Cytomorphological Features of Primary Plasma Cell Leukaemia: A Case Series.
- Published in:
- Journal of Clinical & Diagnostic Research, 2023, v. 17, n. 6, p. 1, doi. 10.7860/JCDR/2023/59121.59121
- By:
- Publication type:
- Article
An Unusual Case of Primary Plasma Cell Leukaemia Mimicking Acute Leukaemia: A Case Report and Review of Literature.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
A Rare Case of Primary Plasma Cell Leukaemia with Monosomy X.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Leukaemic Transformation of Multiple Myeloma in Post Chemotherapy Remission Phase.
- Published in:
- Journal of Clinical & Diagnostic Research, 2016, v. 10, n. 4, p. 23, doi. 10.7860/JCDR/2016/17370.7696
- By:
- Publication type:
- Article
Large plasmacytoma occupying the upper limb in a myeloma patient.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents.
- Published in:
- Rare Tumors, 2012, v. 4, n. 3, p. 123, doi. 10.4081/rt.2012.e39
- By:
- Publication type:
- Article